Inventor · disambiguated record
Annika Sonntag
Also filed as: SONNTAG ANNIKA
22 granted patents·3 pending applications·46 citations·filing 2017–2025
94Inventor score
Files withIMMATICS BIOTECHNOLOGIES GMBH25
Top patents by PatentIndex Score
25 records- 0196US10464991B2Immunotherapy against melanoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Nov 5, 2019·5 cites·20 claims
- 0296US10435454B2Immunotherapy against melanoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Oct 8, 2019·5 cites·20 claims
- 0396US10385110B2Immunotherapy against melanoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Aug 20, 2019·5 cites·20 claims
- 0496US10385111B2Immunotherapy against melanoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Aug 20, 2019·5 cites·20 claims
- 0596US10364281B2Immunotherapy against melanoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Jul 30, 2019·5 cites·20 claims
- 0696US10035838B2Immunotherapy against melanoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Jul 31, 2018·6 cites·20 claims
- 0796US9901629B2Immunotherapy against melanoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2017·Granted Feb 27, 2018·5 cites·15 claims
- 0893US10640547B2Immunotherapy against melanoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted May 5, 2020·5 cites·20 claims
- 0992US2025092104A1Immunotherapy with a*01 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 1090US10435455B1Immunotherapy against melanoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Oct 8, 2019·3 cites·20 claims
- 1187US10519216B2Immunotherapy against melanoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Dec 31, 2019·2 cites·20 claims
- 1282US12195506B2Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Jan 14, 2025·0 cites·20 claims
- 1382US12060399B2Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Aug 13, 2024·0 cites·20 claims
- 1481US10954281B2Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Mar 23, 2021·0 cites·20 claims
- 1579US12227556B2Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Feb 18, 2025·0 cites·17 claims
- 1679US11142556B2Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Oct 12, 2021·0 cites·20 claims
- 1778US11433099B2Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Sep 6, 2022·0 cites·27 claims
- 1877US2019389930A1Immunotherapy against melanoma and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Application pending·0 cites
- 1976US11001617B2Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted May 11, 2021·0 cites·20 claims
- 2076US10899814B2Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·0 cites·20 claims
- 2176US10899812B2Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·0 cites·20 claims
- 2276US10899813B2Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·0 cites·20 claims
- 2376US10870685B2Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Dec 22, 2020·0 cites·20 claims
- 2475US11779605B2Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Oct 10, 2023·0 cites·11 claims
- 2573US2025145684A1Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Annika Sonntag files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →